Content Uniformity and Dose Uniformity: Current Approaches, Statistical Analyses, and Presentation of an Alternative Approach, with Special Reference to Oral Inhalation and Nasal Drug Products
Overview
Affiliations
This article reviews current and proposed approaches to content uniformity testing. In addition, the article proposes an approach that allows regulatory agencies and compendia to clearly state allowable consumer risk. Further, the article suggests that producers be allowed to control producer risk through selection of numbers of units and testing tiers. The approach facilitates risk communication to practitioners and patients/consumers, which is impeded with current approaches, and reduces regulatory and compendial burden.
Ali S, Saad S, Fayed A, Marzouk H BMC Chem. 2024; 18(1):157.
PMID: 39192312 PMC: 11350986. DOI: 10.1186/s13065-024-01265-5.
Minootan Z, Wang H, Connaughton P, Lachacz K, Carrigy N, Ordoubadi M AAPS PharmSciTech. 2024; 25(4):82.
PMID: 38600288 DOI: 10.1208/s12249-024-02776-z.
Manipulation of Spray-Drying Conditions to Develop an Inhalable Ivermectin Dry Powder.
Saha T, Sinha S, Harfoot R, Quinones-Mateu M, Das S Pharmaceutics. 2022; 14(7).
PMID: 35890327 PMC: 9325229. DOI: 10.3390/pharmaceutics14071432.
Vranic E, Uzunovic A Bosn J Basic Med Sci. 2008; 8(2):193-200.
PMID: 18498274 PMC: 5698354. DOI: 10.17305/bjbms.2008.2981.
Oral dosage form performance tests: new dissolution approaches.
Hauck W, Foster T, Sheinin E, Cecil T, Brown W, Marques M Pharm Res. 2005; 22(2):182-7.
PMID: 15783064 DOI: 10.1007/s11095-004-1184-4.